This document provides a 1115-page market report on the clinical chemistry and immunodiagnostics markets from 2013-2023. It details test volumes, sales forecasts, and market shares of leading suppliers for 100 assays in the US, Europe and Japan. The markets will undergo significant changes driven by new regulations, diagnostic technologies, automation, and competition. New opportunities will arise for instruments, reagents, and auxiliary products.